PNS217 DRG PORTFOLIO ANALYSIS OF THE STATE FUNDED HUNGARIAN WAITING-LIST REDUCTION PROGRAM

Abstract

Waiting lists are subject to significant interest in many countries. The waiting-list system in Hungary is fairly transparent. In 2015, the National Health Insurance Fund Administration of Hungary established a waiting-list reduction program with the aim to significantly shorten waiting-lists and waiting times. The aim of the study is to analyze the Diagnosis Related Groups (DRG) portfolio of the waiting list reduction program between 2015-2018. The database of the research contained all of the public-funded cases between 2015-2018, which were financed in the Hungarian waiting-list reduction program, especially the name and the type of the responsible institutes, as well as the name and code of DRGs. The database was provided by the National Health Insurance Fund Administration of Hungary. Between 2015-2018, 24,093 cases were financed in the Hungarian waiting list reduction program. Most of the cases were provided by county hospitals (number of cases: 7,562). According to the DRG main groups, the “eye diseases” (02P; market share= 46.06%) and the “musculoskeletal and connective tissue diseases “(08P; market share= 35.82%) were the most significant among the financed waiting-list cases. The cataract surgery using phacoemulsification with a curved lens implant (DRG: 0680) was the most performed DRG (number of cases=10,963), although the implantation of bicondylar knee joint (DRG: 371E) was also remarkable (number of cases=3,865). The market share of the 10 most performed DRG was 92.49% from all financed DRG. More than 80 DRG was funded in the Hungarian waiting-list reduction program, although there were a significant disbalance among them. The number of cases linked to the cataract waiting- list were remarkable, however cases linked to the hip and knee arthroplasty were also noteworthy.